Cesca Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
20.65 M |
Public Float |
4.61 M |
Cesca Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$22.5 |
Market Cap |
$7.92 M |
Shares Outstanding |
20.65 M |
Public Float |
4.61 M |
Address |
2711 Citrus Road Rancho Cordova California 95742 United States |
Employees | - |
Website | http://www.cescatherapeutics.com |
Updated | 07/08/2019 |
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. |